Efficacy and Safety of Concomitant Chemoradiotherapy ...

Efficacy and safety of concomitant chemoradiotherapy with cisplatin ...

Results: The median age of the patients was 58 years (range, 32-77). Objective response rate was 83.3%. The 2-year progression-free survival (PFS) and overall ...

Efficacy and safety of concomitant chemo-endocrine therapy in ...

In this meta-analysis analyzed the efficacy and safety of randomized controlled trials (RCT) comparing the use of NaCET in HR-positive/HER2-negative BC.

Efficacy and Safety of Concomitant Chemoradiotherapy ... - CiteSeerX

Head and neck cancers comprise 3% of the newly diagnosed cancer patients in the USA. It is thought that. 49.260 new cases with oral cavity, pharynx and ...

Efficacy of concomitant chemoradiotherapy in organ-preserving ...

Patients with muscle-invasive or with high risk T1 tumors (Grade III-IV) or with residual tumor after TURB or with multiple recurrences or lymph node metastases ...

Safety and efficacy of radiotherapy/chemoradiotherapy combined ...

This study suggests that the addition of ICIs to RT/CRT for NSCLC patients may be both safe and feasible.

(PDF) Efficacy and Safety of Concomitant Chemoradiotherapy with ...

PDF | Background: Chemoradiation (CRT) using cisplatin-based regimens has become the standard of care in the treatment of squamous cell head and neck.

Comparison of efficacy and safety of three different chemotherapy ...

Concomitant administration of chemotherapy and radiotherapy is currently recognized as the standard of treatment in locally advanced ...

Full article: Efficacy and safety of concomitant chemo-endocrine ...

Efficacy and safety of concomitant chemo-endocrine therapy in neoadjuvant treatment of hormone-positive HER2-negative breast cancer: a systemic review and meta- ...

an international, multicentre, randomised phase 3 trial - The Lancet

Li, F ∙ Mei, F ∙ Yin, S ∙ et al. Improving the efficacy and safety of concurrent chemoradiotherapy ... concomitant chemotherapy and radiotherapy ...

The toxicity and efficacy of concomitant chemoradiotherapy in ...

... risk of severe late toxicity for patients undergoing concomitant chemoradiotherapy (CCRT).4 Furthermore, older patients have been observed ...

Safety and efficacy of chemotherapy for patients with unresectable ...

Conclusions: Patients with pancreatic cancer concomitant with collagen disease have a high discontinuation rate due to AEs, and attention should ...

Chemoradiotherapy in Cancer Treatment: Rationale and Clinical ...

Thus, a phase III, global, multicentre, double-blind, placebo-controlled, randomized trial has been initiated to evaluate the efficacy and safety of ...

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab ...

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy ... concomitant chemotherapy and radiotherapy ...

Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine ...

Gemcitabine is a radiosensitizing drug that has shown efficacy and safety in this context. The effectiveness of concomitant chemoradiotherapy ...

Articles Concomitant chemoradiotherapy versus acceleration of ...

We aimed to assess the efficacy and safety of a combination of these approaches. Methods. In our open-label phase 3 randomised trial, we enrolled patients ...

The efficacy and safety of induction chemotherapy combined with ...

Induction chemotherapy (IC) combined with concurrent chemoradiotherapy (CCRT) has been recommended as the first-line therapy for ...

Efficacy and safety of concomitant chemo-endocrine therapy in ...

Conclusions NACT could improve survival outcomes for patients with resectable NSCLC, suggesting its suitable future applicability for clinical ...

Efficacy and safety of first-line carboplatin-versus cisplatin-based ...

Sensitivity analyses included using fixed effect models for efficacy endpoints, and removing studies where the concomitant chemotherapy dose differed in the ...

Concomitant chemoradiotherapy versus acceleration of ... - The Lancet

We aimed to assess the efficacy and safety of a combination of these approaches. Methods. In our open-label phase 3 randomised trial, we enrolled patients ...

ORIGINAL ARTICLE - Induction TPF followed by concomitant ...

Cetuximab/RT (CET/RT) is an alternative treatment option to CCRT. The efficacy of induction chemotherapy (IC) followed by chemoradiation ...